Cited 0 times in
GS-003: Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, JW | - |
dc.contributor.author | Kim, YJ | - |
dc.contributor.author | Kim, DY | - |
dc.contributor.author | Bae, SH | - |
dc.contributor.author | Paik, SW | - |
dc.contributor.author | Lee, YJ | - |
dc.contributor.author | Lee, D | - |
dc.contributor.author | Lee, HC | - |
dc.contributor.author | Han, SY | - |
dc.contributor.author | Cheong, JY | - |
dc.contributor.author | Kwon, OS | - |
dc.contributor.author | Yeon, JE | - |
dc.contributor.author | Kim, BH | - |
dc.contributor.author | Hwang, JS | - |
dc.date.accessioned | 2019-12-10T06:53:41Z | - |
dc.date.available | 2019-12-10T06:53:41Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 0168-8278 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/17792 | - |
dc.language.iso | en | - |
dc.title | GS-003: Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 정, 재연 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1016/S0168-8278(18)30222-8 | - |
dc.citation.title | Journal of hepatology | - |
dc.citation.volume | 68 | - |
dc.citation.number | S1 | - |
dc.citation.date | 2018 | - |
dc.citation.startPage | S2 | - |
dc.citation.endPage | S2 | - |
dc.identifier.bibliographicCitation | Journal of hepatology, 68(S1). : S2-S2, 2018 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 1600-0641 | - |
dc.relation.journalid | J001688278 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.